Cargando…
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968857/ https://www.ncbi.nlm.nih.gov/pubmed/8123490 |
_version_ | 1782134832045752320 |
---|---|
author | Rosen, A. C. Sevelda, P. Klein, M. Graf, A. H. Lahousen, M. Reiner, A. Auerbach, L. Vavra, N. Rosen, H. R. |
author_facet | Rosen, A. C. Sevelda, P. Klein, M. Graf, A. H. Lahousen, M. Reiner, A. Auerbach, L. Vavra, N. Rosen, H. R. |
author_sort | Rosen, A. C. |
collection | PubMed |
description | Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account. |
format | Text |
id | pubmed-1968857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19688572009-09-10 A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Rosen, A. C. Sevelda, P. Klein, M. Graf, A. H. Lahousen, M. Reiner, A. Auerbach, L. Vavra, N. Rosen, H. R. Br J Cancer Research Article Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account. Nature Publishing Group 1994-03 /pmc/articles/PMC1968857/ /pubmed/8123490 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Rosen, A. C. Sevelda, P. Klein, M. Graf, A. H. Lahousen, M. Reiner, A. Auerbach, L. Vavra, N. Rosen, H. R. A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title | A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title_full | A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title_fullStr | A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title_full_unstemmed | A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title_short | A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. |
title_sort | comparative analysis of management and prognosis in stage i and ii fallopian tube carcinoma and epithelial ovarian cancer. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968857/ https://www.ncbi.nlm.nih.gov/pubmed/8123490 |
work_keys_str_mv | AT rosenac acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT seveldap acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT kleinm acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT grafah acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT lahousenm acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT reinera acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT auerbachl acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT vavran acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT rosenhr acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT rosenac comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT seveldap comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT kleinm comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT grafah comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT lahousenm comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT reinera comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT auerbachl comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT vavran comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer AT rosenhr comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer |